SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Rezolve AI Plc operates in the mobile commerce industry with its cutting-edge engagement platform powered by artificial intelligence and machine learning. It develops AI-based mobile commerce and engagement solutions, simplifying the purchasing process by providing relevant information and facilitating seamless transactions with a single tap. The company enables retailers, brands, and manufacturers to create dynamic connections with consumers across mobile and desktop devices. Rezolve Ai was founded in 2016 and is headquartered in London, the United Kingdom.

Rezolve AI PLC .

Rezolve AI Limited

Rezolve AI ($RZLV) is trending due to positive community sentiment and a leadership change. News of Rezolve Ai Strengthening Leadership with Appointment of Former Microsoft Retail Head Crispin Lowery as EVP, Growth is driving excitement. Many investors express bullish sentiment, speculating on potential price increases and highlighting partnerships with Google and Microsoft.

TMC the metals co., Inc. is a deep-sea minerals exploration company focused on the collection and processing of polymetallic nodules found on the seafloor in international waters of the Clarion Clipperton Zone in the Pacific Ocean (CCZ). These nodules contain high grades of four metals (nickel, copper, cobalt, manganese) which can be used as (i) feedstock for battery cathode precursors (nickel, cobalt and manganese sulfates, or intermediate nickel-copper-cobalt matte) for electric vehicles (EV) and renewable energy storage markets, (ii) copper cathode for EV wiring, energy transmission and other applications and (iii) manganese silicate for manganese alloy production required for steel production. The company was founded in 2021 and is headquartered in Vancouver, Canada.

TMC the metals company Inc

TMC is trending as investors discuss the potential impact of upcoming congressional hearings related to offshore critical minerals. The community is focused on regulatory progress and potential government support for the deep-sea mining sector. Bullish sentiment is reflected in the stock's pre-market activity and optimism about the company's future.

The Trade Desk, Inc. engages in the provision of a self-service and cloud-based ad-buying platform. It operates through the United States and International geographical segments. The firm offers omnichannel advertising, audience targeting, solutions for identity, application programming interface (API), custom, and programmatic, measurement and optimization. The company was founded by Jeffrey Terry Green and David Pickles in November 2009 and is headquartered in Ventura, CA.

Trade Desk Inc - Ordinary Shares - Class A

Trade Desk Inc

TTD is trending due to concerns about competition and slowing growth, despite strong fundamentals, with a recent analyst downgrade adding to the negative sentiment. The community is actively debating whether the stock is oversold or a value trap, with some pointing to a potential short squeeze. Some are attributing the recent drop to premarket share sales and expressing frustration with management's silence.

BigBear.ai Holdings, Inc. engages in data-driven decision dominance and advanced analytics that provide its customers with a competitive advantage in a world driven by data that is growing in terms of volume, variety, and velocity. The firm operationalizes artificial intelligence and machine learning at scale through its end-to-end data analytics platform. It deploys its observe, orient and dominate products to customers throughout the defense, intelligence, and commercial markets. The company was founded in 2020 and is headquartered in McLean, VA.

BigBear.ai Holdings Inc

BigBear.ai is trending amid retail trader speculation around potential government contracts, fueled by a recent congressional disclosure of stock purchases. The community is drawing comparisons to Palantir ($PLTR) and actively discussing the potential for a short squeeze and breakout. Bullish investors are focusing on AI-driven solutions, chart patterns, and the growing interest in AI for defense and security.

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Capricor Therapeutics is trending as investors discuss the potential for upcoming news and a path forward for its drug, Deramiocel, following recent FDA feedback. Community talking points revolve around a letter circulating among political leaders, its potential impact on the FDA's decision, and speculation on the timing of a response. Some traders are weighing the possibility of accelerated approval, the significance of HOPE-3 trial data, and potential catalysts for a short squeeze.

MP Materials Corp. engages in the production and marketing of rare earth specialty materials. It operates through the Materials and Magnetics segments. The Materials segment focuses on the operation of Mountain Pass, which produces refined rare earth oxides and related products, as well as rare earth concentrate products. The Magnetics segment is involved in the operation of Independence Facility, where the company began production of magnetic precursor products. The company was founded by James Henry Litinsky and Michael Rosenthal in 2017 and is headquartered in Las Vegas, NV.

MP Materials Corporation

MP Materials is trending as the U.S. government considers increasing its investment in critical minerals, potentially redirecting funds from the CHIPS Act, which has sparked community interest and debate. The community is discussing the potential impact of government support on MP's growth, comparing it to past investments, and weighing the company's strategic importance in reducing reliance on foreign suppliers amid rising demand for rare earth elements. Some traders are closely watching technical indicators and options activity, while others express concerns about competition and sector-wide market dynamics.

Chipotle Mexican Grill, Inc. engages in the business of developing and operating restaurants that serve a relevant menu of burritos, burrito bowls, quesadillas, tacos, and salads made using fresh, high-quality ingredients. The company was founded by Steve Ells in 1993 and is headquartered in Newport Beach, CA.

Chipotle Mexican Grill

Chipotle is trending due to a newly announced $500 million share repurchase program, though some investors question whether buybacks are the best use of capital amid concerns about same-store sales and insider selling. The community is actively debating the stock's valuation, potential for a bounce, and long-term prospects in an increasingly competitive fast-casual market. Some are drawing comparisons to competitors like CAVA and highlighting concerns around the company's leadership and stock performance.

Jumia Technologies AG engages in the provision of logistic services. It operates a pan-African e-commerce platform. It operates through the following geographical segments: West Africa, North Africa, East and South Africa, Europe, United Arab Emirates, and Others. The company was founded by Jeremy Hodara, Sacha Poignonnec, Peter Allerstorfer, Manuel Koser, Tunde Kehinde, and Raphael Afaedor in 2012 and is headquartered in Berlin, Germany.

Jumia Technologies Ag - ADR

Jumia ($JMIA) is trending as RBC Capital upgraded the stock to Outperform, citing expectations for supply expansion and order growth, coupled with easing currency pressures. The community is buzzing with excitement, interpreting this upgrade as a signal of significant potential and a possible short squeeze. Some traders are drawing parallels to past rallies and anticipating further upward movement, while others caution about volatility and potential pullbacks.

Bloom Energy Corp. engages in the manufacture and installation of a solid oxide fuel-cell based power generation platform. Its product, Bloom Energy Server, converts standard low-pressure natural gas or biogas into electricity through an electrochemical process without combustion. The company was founded by K. R. Sridhar, John Finn, Jim McElroy, Matthias Gottmann, and Dien Nguyen on January 18, 2001, and is headquartered in San Jose, CA.

Bloom Energy Corp - Ordinary Shares - Class A

Bloom Energy Corp

Bloom Energy is trending following news of a potential surge in demand for its fuel cell technology to power AI data centers, underscored by a recent analyst upgrade and new partnerships. The community is discussing the company's potential for significant growth and whether the current valuation is justified, with some speculating about a possible short squeeze given the high short interest. Broader conversations revolve around the increasing energy demands of AI and Bloom Energy's positioning within the clean energy sector to meet those demands.

$WAGMI is a community-driven meme token built on the Solana blockchain, designed to bring positivity, unity, and humor into the crypto space. The project encourages community engagement through memes, social interaction, and token-based activities. It leverages Solana’s fast and low-cost infrastructure to allow for smooth on-chain interactions, such as token transfers, community games, and NFT integration. The goal is to foster a fun, inclusive ecosystem where holders feel they are part of a larger movement – "We Are Gonna Make It."

WAGMI

$WAGMI.X is trending as the community rallies around its core message: We're All Gonna Make It. Many are drawing comparisons to the early days of other successful meme coins, emphasizing the strong community and potential for significant growth within the Solana ecosystem. The coin is being promoted as more than just a meme, but a movement.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Best Momentum Stock to Buy for August 19th

CENX, MC and HCM made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on August 19, 2025.

How Much Upside is Left in HUTCHMED (HCM)? Wall Street Analysts Think 73.52%

Wall Street Analysts See a 68.3% Upside in HUTCHMED (HCM): Can the Stock Really Move This High?

Shares of Hutchmed (China) hit their highest levels in over a month after the company announced along with Innovent Biologics that their NDA for a kidney cancer treatment had been accepted by China's drug regulator.At the close on Wednesday, Hutchmed shares rose 4.1% to $15.3, with an additional 0.5% gain to $15.38 in after-hours trading.The China National Medical Products Administration (NMPA) accepted for review the NDA for fruquintinib combined with sintilimab as a treatment for patients with advanced renal cell carcinoma who did not respond to tyrosine kinase inhibitor therapy, according to a joint company statement.Results of the FRUSICA-2 trial showed the drug met its primary progression-free survival goal and also improved secondary measures such as objective response rate and duration of response.“Submitting this NDA...marks an important step in our efforts to address this unmet need,” said Michael Shi, head of R&amp;D and chief medical officer at Hutchmed.Hui Zhou, senior vice president at Innovent, said the filing represents the tenth indication for sintilimab, calling it a milestone in lifecycle management.The combination therapy received conditional approval from the NMPA in December 2024 for patients with advanced mismatch repair proficient endometrial cancer.Fruquintinib is approved in China under the brand Elunate and is marketed globally as Fruzaqla by Takeda.&nbsp;Sintilimab, co-developed by Innovent and Eli Lilly, is approved for multiple indications and included in China’s national reimbursement list.On Stocktwits, retail sentiment was ‘neutral’ amid ‘high’ message volume.The stock has risen 1.5% so far in 2025.For updates and corrections, email newsroom[at]stocktwits[dot]com.

Illustration depicting tumour infiltrating lymphocyte (TIL) therapy for cancer treatment. During TIL therapy, T-cells (blue) that recognise tumour cells (red) are obtained from a patient. | Image source: Getty Images

Hutchmed Stock Hits Over One-Month High After China Accepts Kidney Cancer NDA Filed With Partner Innovent Biologics

China's drug regulator accepted the companies’ NDA for a combination therapy targeting advanced renal cell carcinoma.

Equity

Innovent and HUTCHMED Jointly Announce NMPA Conditional Approval for TYVYT (Sintilimab Injection) in Combination with ELUNATE (Fruquintinib) for the Treatment of Advanced Endometrial Cancer

Innovent and HUTCHMED Jointly Announce NMPA Conditional Approval for TYVYT (Sintilimab Injection) in Combination with ELUNATE (Fruquintinib) for the Treatment of Advanced Endometrial Cancer Innovent...

FDA Approves 16 New Cancer Treatments as Global Cancer Rates Skyrocket

FDA Approves 16 New Cancer Treatments as Global Cancer Rates Skyrocket FDA Approves 16 New Cancer Treatments as Global Cancer Rates Skyrocket PR Newswire VANCOUVER, BC, Oct. 4, 2024 USA News Group...

HUTCHMED Updates Share Capital and Voting Rights

HUTCHMED (China) Limited (HK:0013) has released an update. HUTCHMED (China) Limited has announced its total number of voting rights, revealing an i...

HUTCHMED to Unveil New Cancer Drug Data at AACR 2024

Hutchmed (China) Limited (HCM) has released an update. HUTCHMED (China) Limited is set to present new and updated data on its cancer treatment comp...

HUTCHMED (China) (HCM, $16.77) entered Downtrend as Momentum indicator drops below 0 level on Apr 01, 2024

This indicator may be signaling that HCM's price has further to drop, since it moved below its price 14 days ago. Traders may consider selling the stock, shorting the stock, or exploring put options...

HUTCHMED (China) (HCM, $16.85) entered Downtrend as Momentum indicator drops below 0 level on Mar 27, 2024

HUTCHMED (China) Ltd. is a holding company, which engages in the research and development, manufacture, and sale of pharmaceuticals and health-oriented consumer products. It operates through the Oncology/Immunology and Other Ventures segments. The Oncology/Immunology segment includes the discovery, development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The Other Ventures segment involves the other commercial businesses which include the sales, marketing, manufacture, and distribution of prescription drugs and healthcare products. The company was founded on December 18, 2000 and is headquartered in Hong Kong.

HUTCHMED (China) Limited - ADR

Cut 25 bps

Cut 50+ bps

No change

Hike 25 bps

It’s Fed Decision Week. Polymarket gives a 90% chance of a 25 bps cut. What’s your call? 
 
*Powered by Polymarket

HCM
Hutchison China MediTech

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest HCM News

HCM Hutchison China MediTech